Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

NovoCure Limited - Ordinary Shares (NQ: NVCR )

31.90 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EST, Dec 26, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about NovoCure Limited - Ordinary Shares

< Previous 1 2
...
11 12 13 14 15 16 17 18 Next >
The Daily Biotech Pulse: MEI Pharma Wilts On Adverse Regulatory Development, Decision Day For Zogenix, AN2 Therapeutics IPO
Here's a roundup of top developments in the biotech space over the last 24 hours. 
Via Benzinga
Updated 2-THE-TOP Data Suggest Improvements in Progression-Free Survival, Overall Survival Compared to Matched-Control Patients from EF-14 Trial
From Novocure
Via Business Wire
Novocure Announces Favorable Recommendation to Continue the Phase 3 Pivotal INNOVATE-3 Study of Tumor Treating Fields in Ovarian Cancer
From Novocure
Via Business Wire
Where NovoCure Stands With Analysts
NovoCure (NASDAQ:NVCR) has observed the following analyst ratings within the last quarter: 
Via Benzinga
Up On Bad News
Despite the plane crash in China, Boeing's stock is up today. 
Via Talk Markets
Lucky Day
Today Alleghany rose nearly 25% because it is being bought by Berkshire Hathaway, Warren Buffett's fund. 
Via Talk Markets
World Markets News For Friday
Buoyant global markets are closing the week and one good performer, Vir Biotech, today gained an impressive 6.09%. 
Via Talk Markets
Novocure Founder Yoram Palti Wins 2022 Israel Prize in Entrepreneurship and Technological Innovation
From Novocure
Via Business Wire
Novocure’s General Counsel Resigns After 10 Years of Service
From Novocure
Via Business Wire
Novocure Q4 Earnings Miss Street View, New Data Shows TTFields Initiates Downstream Anti-Tumor Response
A new study published in the Journal of Clinical Investigation (JCI) finds treatment with Novocure Ltd's (NASDAQ: NVCR) Tumor Treating Fields (TTFields) mediated... 
Via Benzinga
New Data Finds Tumor Treating Fields Initiates Downstream Anti-Tumor Response
From Novocure
Via Business Wire
Novocure Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Company Update
From Novocure
Via Business Wire
Bionano Stock Looks to Have a Monster Comeback in Its Future
Bionano's Saphyr appears to be able to help doctors treat leukemia, and the adoption of its device is growing rapidly. 
Via InvestorPlace
Give peace a chance
Israeli fabless semiconductor maker Tower was bought by Intel for $5.4 bn today. 
Via Talk Markets
12 Health Care Stocks Moving In Wednesday's After-Market Session
Gainers Bone Biologics (NASDAQ:BBLG) shar... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For February 8, 2022
Upgrades According to Consumer Edge Research, the prior rating for The Hain Celestial Group Inc (NASDAQ:HAIN) was changed from Equal-Weight to Overweight. For the second... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For February 2, 2022
Upgrades Oppenheimer upgraded the previous rating for NovoCure Ltd (NASDAQ:NVCR) from Perform to Outperform. NovoCure earned $0.13 in the third quarter, compared to $0.09... 
Via Benzinga
World Markets News
Today oil and gas inventories were seen as higher than expected while potential prices fell, both bullish. 
Via Talk Markets
Benzinga's Top Ratings Upgrades, Downgrades For January 20, 2022
Upgrades For W.P. Carey Inc (NYSE:WPC), B... 
Via Benzinga
Cramer Gives His Opinion On Novocure, InMode, Virgin Galactic And More
On CNBC’s "Mad Money Lightning Round," Jim Cramer said Atkore (NASDAQ: 
Via Benzinga
Biotech Bloodbath Continues Despite Gene-Editing Deals For Pfizer, Bayer
Pfizer and Bayer inked deals with several companies in gene-editing. 
Via Investor's Business Daily
Novocure Announces Preliminary Full Year and Fourth Quarter 2021 Net Revenues and Provides Company Update
From Novocure
Via Business Wire
10 Health Care Stocks With Whale Alerts In Today's Session
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our... 
Via Benzinga
7 Pharmaceutical Stocks That Could Make You Rich
Due to expiring patents and rising competition, successful pharmaceutical stocks need to develop robust drug pipelines. 7 Pharmaceutical Stocks That Could Make You Rich 
Via InvestorPlace
Stocks That Hit 52-Week Lows On Wednesday
Before 10 am on Wednesday, 99 companies set new 52-week lows. Facts of Interest About Today's 52-Week Lows: Sea (NYSE:SE) was the largest firm by market cap to set a... 
Via Benzinga
Novocure to Participate in the 40th Annual J.P. Morgan Healthcare Conference
From Novocure
Via Business Wire
Start Of 2022
Mohammed El Erien predicts that the Fed will be slamming on the brakes this year. 
Via Talk Markets
Happy New Year - Sunday Edition
Starting a new year - we look at tech, pharma and mining stocks and their goings-on. 
Via Talk Markets
Stocks Hitting New 52-Week Lows Today
On Monday morning, 60 companies achieved new lows for the year. Points of Interest From Today's 52-Week Lows And Highs: Ginkgo Bioworks Holdings (NYSE:DNA) was... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For January 3, 2022
Upgrades For nVent Electric PLC (NYSE:NVT), Vertica... 
Via Benzinga
< Previous 1 2
...
11 12 13 14 15 16 17 18 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.